<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.1 20050630//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?open_access?><front><?epub 24-February-2005?><journal-meta><journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id><journal-id journal-id-type="publisher-id">Nucleic Acids Research</journal-id><journal-title>Nucleic Acids Research</journal-title><issn pub-type="ppub">0305-1048</issn><issn pub-type="epub">1362-4962</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1093/nar/gki263</article-id><article-id pub-id-type="pmid">15731339</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Separation of mutation avoidance and antirecombination functions in an <italic>Escherichia coli mutS</italic> mutant</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Calmann</surname><given-names>Melissa A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Nowosielska</surname><given-names>Anetta</given-names></name></contrib><contrib contrib-type="author"><name><surname>Marinus</surname><given-names>M. G.</given-names></name><xref ref-type="corresp" rid="cor1">*</xref></contrib><aff><institution>Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School</institution><addr-line>364 Plantation Street, Worcester, MA 01605, USA</addr-line></aff></contrib-group><author-notes><corresp id="cor1"><sup>*</sup>To whom correspondence should be addressed. Tel: +1 508 856 3330; Fax: +1 508 856 3036; Email: <email>Martin.Marinus@umassmed.edu</email></corresp></author-notes><!--For NAR: both ppub and collection dates generated for PMC processing 1/27/05 beck--><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="ppub"><year>2005</year></pub-date><pub-date pub-type="epub"><day>24</day><month>2</month><year>2005</year></pub-date><volume>33</volume><issue>4</issue><fpage>1193</fpage><lpage>1200</lpage><history><date date-type="received"><day>05</day><month>1</month><year>2005</year></date><date date-type="rev-recd"><day>02</day><month>2</month><year>2005</year></date><date date-type="accepted"><day>02</day><month>2</month><year>2005</year></date></history><copyright-statement>&#x000a9; The Author 2005. Published by Oxford University Press. All rights reserved</copyright-statement><copyright-year>2005</copyright-year><license license-type="openaccess"><p>The online version of this article has been published under an open access model. Users are entitled to use, reproduce, disseminate, or display the open access version of this article for non-commercial purposes provided that: the original authorship is properly and fully attributed; the Journal and Oxford University Press are attributed as the original place of publication with the correct citation details given; if an article is subsequently reproduced or disseminated not in its entirety but only in part or as a derivative work this must be clearly indicated. For commercial re-use, please contact <email>journals.permissions@oupjournals.org</email></p></license><abstract><p>DNA mismatch repair in <italic>Escherichia coli</italic> has been shown to be involved in two distinct processes: mutation avoidance, which removes potential mutations arising as replication errors, and antirecombination which prevents recombination between related, but not identical (homeologous), DNA sequences. We show that cells with the <italic>mutS</italic>&#x00394;<italic>800</italic> mutation (which removes the C-terminal 53 amino acids of MutS) on a multicopy plasmid are proficient for mutation avoidance. In interspecies genetic crosses, however, recipients with the <italic>mutS</italic>&#x00394;<italic>800</italic> mutation show increased recombination by up to 280-fold relative to <italic>mutS</italic><sup>+</sup>. The MutS&#x00394;800 protein binds to <italic>O</italic><sup>6</sup>-methylguanine mismatches but not to intrastrand platinated GG cross-links, explaining why <italic>dam</italic> bacteria with the <italic>mutS</italic>&#x00394;<italic>800</italic> mutation are resistant to cisplatin, but not MNNG, toxicity. The results indicate that the C-terminal end of MutS is necessary for antirecombination and cisplatin sensitization, but less significant for mutation avoidance. The inability of MutS&#x00394;800 to form tetramers may indicate that these are the active form of MutS.</p></abstract></article-meta></front><body><sec><title>INTRODUCTION</title><p>The Dam-directed mismatch repair (MMR) system of <italic>Escherichia coli</italic> removes potential mutations arising as replication errors (mutation avoidance) (<xref ref-type="bibr" rid="b1">1</xref>&#x02013;<xref ref-type="bibr" rid="b3">3</xref>). Correction of biosynthetic errors by MMR occurs directly after replication, just behind the replication fork, where the parental DNA strand is fully methylated at GATC (<italic>dam</italic>) sequences and the newly synthesized strand is not yet methylated. When base mispairs arise in such hemi-methylated DNA, they are bound initially by the MutS protein which subsequently recruits MutL and MutH to form a ternary complex. Incision by activated MutH occurs on the unmethylated strand at a nearby GATC sequence, followed by excision, in either the 3&#x02032; or 5&#x02032; direction, of the mismatched base pair and surrounding sequence. Re-synthesis by the replicative polymerase, DNA polymerase III, restores the correct nucleotide sequence and the resulting nick is sealed by DNA ligase to complete the repair process. Subsequently, the repaired DNA strand is methylated at GATC sequences by Dam methyltransferase and this methylation prevents further MMR action. This model has both genetic and biochemical support including a mutator phenotype associated with <italic>mutS</italic> mutants (<xref ref-type="bibr" rid="b1">1</xref>,<xref ref-type="bibr" rid="b2">2</xref>).</p><p>MMR also plays a role in preventing recombination between related, but not identical (homeologous), DNA sequences (anti-recombination) (<xref ref-type="bibr" rid="b4">4</xref>). Genetic crosses between <italic>E.coli</italic> and <italic>Salmonella enterica</italic> Serovar <italic>Typhimurium</italic> are sterile unless the recipient contains mutations in the <italic>mutS</italic> or <italic>mutL</italic> MMR genes. This result suggests that MMR either impedes or actively reverses recombination intermediates or destroys them, with the former having some experimental support (<xref ref-type="bibr" rid="b5">5</xref>&#x02013;<xref ref-type="bibr" rid="b7">7</xref>). On a biochemical level, MutS and MutL block RecA-mediated strand exchange between the fd and M13 genomes, which are 3% divergent, but not between M13&#x02013;M13 genomes (<xref ref-type="bibr" rid="b8">8</xref>). In the homeologous reaction, MutS has a greater effect than MutL, which is effective only in combination with MutS. The intimate connection between mutation avoidance and antirecombination is shown by the phenotype of <italic>E.coli mutS</italic> mutations which are defective in both these processes (<xref ref-type="bibr" rid="b4">4</xref>). A survey of a large number of <italic>E.coli mutS</italic> mutants failed to detect any with only one of the phenotypes (<xref ref-type="bibr" rid="b9">9</xref>). Similarly, we have been unable to find a mutant with only one of these phenotypes among a collection of dominant-negative alleles (<xref ref-type="bibr" rid="b10">10</xref>).</p><p><italic>E.coli dam</italic> mutants are more sensitive to the cytotoxic action of cisplatin and <italic>N</italic>-methyl-<italic>N</italic>&#x02032;-nitro-<italic>N</italic>-nitrosoguanidine (MNNG) than wild type (<xref ref-type="bibr" rid="b11">11</xref>,<xref ref-type="bibr" rid="b12">12</xref>). Mutations in genes that incapacitate MMR (<italic>mutS</italic>, <italic>mutL</italic> or <italic>mutH</italic>) in a <italic>dam</italic> background confer a level of resistance to these agents similar to that of the wild type. This result indicates that inappropriate MMR on chemically modified DNA can sensitize <italic>dam</italic> cells to these cytotoxic agents (<xref ref-type="bibr" rid="b11">11</xref>&#x02013;<xref ref-type="bibr" rid="b13">13</xref>). MMR in wild-type cells is restricted to one strand in the hemimethylated region behind the replication fork because MutH endonuclease cannot use fully methylated DNA as a substrate. In <italic>dam</italic> mutants, however, MMR can occur on either strand anywhere on the chromosome because MutH can use unmethylated DNA as a substrate. It has been proposed that MMR-induced single-strand breaks or gaps can be converted to double-strand breaks (DSBs) either by MutH action at the same GATC sequence on the opposite strand (<xref ref-type="bibr" rid="b14">14</xref>) or by replication fork collapse (<xref ref-type="bibr" rid="b15">15</xref>,<xref ref-type="bibr" rid="b16">16</xref>). The DSBs so formed require recombination for their repair thereby making recombination essential for viability (<xref ref-type="bibr" rid="b15">15</xref>). As a result of these DSBs, recombination capacity is limiting (<xref ref-type="bibr" rid="b15">15</xref>) and when <italic>dam</italic> cells are exposed to cisplatin a large number of DSBs accumulate (<xref ref-type="bibr" rid="b16">16</xref>). MMR is required for the formation of cisplatin-induced DSBs (<xref ref-type="bibr" rid="b16">16</xref>) suggesting that they probably occur at cisplatin lesions undergoing MMR at either unreplicated lesions or those formed with mismatches after the action of translesion polymerases. The accumulation of DSBs in <italic>dam</italic> mutants, which have limited recombination capacity, and the reduced ability of MutS to prevent RecA-mediated strand transfer of platinated DNA during recombinational repair (<xref ref-type="bibr" rid="b17">17</xref>) provides a plausible model to explain why MMR sensitizes <italic>dam</italic> cells to cisplatin.</p><p>To explain MMR sensitization of <italic>E.coli dam</italic> mutants by MNNG, the &#x02018;futile cycling&#x02019; model was proposed (<xref ref-type="bibr" rid="b11">11</xref>). In this model, the replicative polymerase inserts either a T or C opposite template O<sup>6</sup>-methylguanine (O<sup>6</sup>-meG). Since neither of these bases is considered a &#x02018;good&#x02019; match by the MMR system, a futile cycle of insertion and removal ensues preventing progression of the replication fork. Such futile cycling in <italic>dam</italic> mutants can also occur at sites away from the replication fork as a consequence of MMR recognition and MutH incision on unmethylated DNA at O<sup>6</sup>-meG&#x02013;C base pairs to promote DSB formation (<xref ref-type="bibr" rid="b13">13</xref>).</p><p>The MutS protein binds specifically to heteroduplex DNA containing base mismatches (<xref ref-type="bibr" rid="b18">18</xref>) or with greatest affinity to small insertion/deletion loops (IDLs) (<xref ref-type="bibr" rid="b19">19</xref>). It also binds platinated GG intrastrand cross-links (<xref ref-type="bibr" rid="b20">20</xref>) and O<sup>6</sup>-meG mispaired with either C or T (<xref ref-type="bibr" rid="b21">21</xref>). The crystal structure of <italic>E.coli</italic> MutS bound to an oligonucleotide with a G&#x02013;T mismatch has been solved using a derivative of the MutS protein, MutS&#x00394;800, which lacks the C-terminal 53 amino acids (<xref ref-type="bibr" rid="b22">22</xref>). The MutS&#x00394;800 mutant crystallizes as a dimer and retains the ability to bind DNA and ATP, just as full-length MutS does (<xref ref-type="bibr" rid="b22">22</xref>). Further analysis into the properties of the MutS and MutS&#x00394;800 proteins by equilibrium sedimentation and gel filtration show that MutS dimers can assemble into higher order oligomeric structures, while the MutS&#x00394;800 mutant is restricted to dimer formation only (<xref ref-type="bibr" rid="b23">23</xref>). The ability of MutS to form tetramers suggests this oligomeric state is important in MutS function. A similar conclusion was reached with the MutS protein from <italic>Thermus</italic> species (<xref ref-type="bibr" rid="b24">24</xref>,<xref ref-type="bibr" rid="b25">25</xref>) for which a crystal structure is also available (<xref ref-type="bibr" rid="b26">26</xref>).</p><p>In this report, we show that the C-terminal end of MutS is critical for antirecombination and cisplatin sensitization, but less significant for mutation avoidance.</p></sec><sec sec-type="materials|methods"><title>MATERIALS AND METHODS</title><sec><title>Strains, plasmids and media</title><p>Strains GM3819 (&#x00394;<italic>dam-16</italic>::Kan), GM4799 (<italic>mutS458::m</italic>Tn<italic>10</italic>Kan), GM5550 (<italic>recA56 mutS458::m</italic>Tn<italic>10</italic>Kan) and GM5556 (&#x00394;<italic>dam-16</italic>::Kan <italic>mutS215</italic>::Tn<italic>10</italic>) are derivatives of AB1157 (<italic>thr-1 ara-14 leuB6</italic> &#x00394;<italic>(gpt-proA)62 lacY1 tsx-33 supE44 galK2 hisG4 rfbD1 mgl-51 rpsL31 kdgK51 xyl-5 mtl-1 argE3 thi-1</italic>). AB259 (HfrH) was obtained from E.A. Adelberg (Yale University). <italic>Salmonella</italic> strains SA536 and SA977 were obtained from the <italic>Salmonella</italic> Genetic Stock Centre, University of Calgary, Canada. Plasmids with the <italic>mutS</italic>&#x00394;C800 (<xref ref-type="bibr" rid="b22">22</xref>) (referred to as <italic>mutS</italic>&#x00394;800 in this paper) and <italic>mutS</italic>&#x00394;<italic>680</italic> (<xref ref-type="bibr" rid="b27">27</xref>) were derived from pMQ372 (<xref ref-type="bibr" rid="b27">27</xref>) carrying the <italic>mutS</italic><sup>+</sup> gene. Full descriptions of strains and plasmids can be found at <ext-link ext-link-type="uri" xlink:href="http://users.umassmed.edu/martin.marinus/dstrains.html"/>. Bacteriological media have been described previously (<xref ref-type="bibr" rid="b15">15</xref>,<xref ref-type="bibr" rid="b28">28</xref>) except for the MacConkey Agar Base (Difco) medium which was supplemented with 50 g/l galactose. Ampicillin, rifampicin and streptomycin were included in media, when required, at 100 &#x003bc;g/ml.</p></sec><sec><title>Estimation of mutant frequency, conjugational crosses and cytotoxicity</title><p>Spontaneous mutant frequencies were measured as described elsewhere (<xref ref-type="bibr" rid="b28">28</xref>,<xref ref-type="bibr" rid="b29">29</xref>) and conjugation experiments were performed as described previously (<xref ref-type="bibr" rid="b15">15</xref>) except that mating mixtures were incubated for 1 h at 37&#x000b0;C for homologous crosses and 3 h for the homeologous crosses. Cell survival after exposure to cisplatin or MNNG was measured as described previously (<xref ref-type="bibr" rid="b11">11</xref>,<xref ref-type="bibr" rid="b29">29</xref>).</p></sec><sec><title>Proteins and DNA</title><p>MutS protein was purchased from USB and dialyzed before use against 20 mM KPO4, pH 7.4, 0.1 mM EDTA, 1 mM PMSF and 10 mM beta-mercaptoethanol. We found that heteroduplex binding (see below) and ATPase specific activity (data not shown) were the same as that for the MutS&#x00394;800 protein. MutL protein was a gift from F. Lopez de Saro and M. O'Donnell (Rockefeller University). MutS&#x00394;800 was purified from strain GM7854 [p<italic>mutS&#x00394;800</italic>/BL21(lambdaDE3)]. Briefly, the cells were grown at 37&#x000b0;C to an OD<sub>600</sub> of 0.8 and shifted to 26&#x000b0;C for induction with 1 mM IPTG. The cells were grown for an additional 3 h at 26&#x000b0;C before harvesting. The cells were lysed using a Microfluidizer (Microfluidics Corp.) and then centrifuged at 27&#x02009;000 <italic>g</italic> for 30 min. The supernatant was treated with streptomycin sulfate and ammonium sulfate as described previously (<xref ref-type="bibr" rid="b18">18</xref>). The resulting fraction was loaded onto a heparin agarose column (Amersham Pharmacia) and eluted with a linear gradient of 100&#x02013;400 mM KCl. The fractions containing MutS were subsequently loaded onto a ceramic hydroxylapatite column (Sigma) and eluted using a linear concentration gradient of 20&#x02013;120 mM KCl. This produced a single MutS peak eluting at 50&#x02013;70 mM KCl. Fractions containing MutS&#x00394;800 were pooled, concentrated using a Centriprep column (Millipore) and frozen at &#x02212;75&#x000b0;C. The protein was at least 95% pure as determined by SDS&#x02013;PAGE analysis. Protein concentration was determined by ninhydrin analysis (<xref ref-type="bibr" rid="b30">30</xref>).</p><p>M13mp18 DNA RFI and single-stranded circular DNA forms were from New England Biolabs (NEB). The RFI form was digested with DraIII and BglII restriction endonucleases (NEB) to remove <italic>lac</italic> operon DNA. Single-stranded circular DNA of bacteriophage fd was prepared by growing a culture of strain AB259 to about 1 &#x000d7; 10<sup>8</sup> cells, adding fd at an m.o.i of 1 and allowing the culture to grow for an additional 3&#x02013;4 h. The culture was centrifuged to remove bacteria, and 20% polyethyleneglycol 8000 and 2.5 M NaCl solution were added to the supernatant (1:3) and left on ice for 30 min. The mixture was centrifuged at 9500 <italic>g</italic> for 10 min and the phage pellet resuspended in TE buffer. The DNA was phenol extracted, ethanol precipitated and its concentration determined by UV spectroscopy.</p></sec><sec><title>Heteroduplex construction, electrophoretic mobility shift assay and RecA strand exchange assay</title><p>Heteroduplex DNA with a single IDL and labeled with P<sup>32</sup> was constructed and analyzed by electrophoretic mobility shift assay as described previously (<xref ref-type="bibr" rid="b19">19</xref>,<xref ref-type="bibr" rid="b27">27</xref>). The oligonucleotide 5&#x02032;-ATACGGAAGTTAAAGTO<sup>6</sup>meGCGGATCATCTCTAG-3&#x02032; (Sigma-Genosys) was annealed with its complementary sequence to form either O<sup>6</sup>meG&#x02013;C or O<sup>6</sup>meG&#x02013;T base pairs. A DNA oligonucleotide provided by Jennifer Robbins and J.M. Essigmann (MIT), designated Xlink (5&#x02032;-CCT CTC CTT GGT CTT CTC CTC TCC-3&#x02032;) contains a cisplatin cross-link between the two guanines and was annealed to its complementary sequence to form either GG&#x02013;CC or GG&#x02013;CT mismatches. The platinated and methylated oligonucleotides were not radiolabeled. The P<sup>32</sup>-labeled DNA and the methylated and platinated DNA, which were stained with Vistra Green (Amersham-Pharmacia) for 1 h, were quantitated using a Fuji Phosphorimager. RecA-mediated strand transfer was performed and measured as described except that M13 and fd molecules were used in place of the phiX174 molecules used previously (<xref ref-type="bibr" rid="b17">17</xref>).</p></sec></sec><sec><title>RESULTS</title><sec><title>Spontaneous mutation frequency of wild-type and <italic>mutS</italic> strains</title><p>Strain GM4799, a <italic>mutS</italic> null mutant (<xref ref-type="bibr" rid="b27">27</xref>), was transformed with plasmids bearing the <italic>mutS</italic><sup>+</sup>, <italic>mutS</italic>&#x00394;<italic>680</italic> and <italic>mutS</italic>&#x00394;<italic>800</italic> genes. The <italic>mutS</italic>&#x00394;<italic>680</italic> and <italic>mutS</italic>&#x00394;<italic>800</italic> designations indicate where the 853 amino acid MutS protein was truncated. The <italic>mutS</italic>&#x00394;<italic>680</italic> mutation has a null mutator phenotype and the MutS&#x00394;680 protein is unable to form oligomers and has reduced ability to interact with MutL (<xref ref-type="bibr" rid="b27">27</xref>). It is used in experiments presented here as the null <italic>mutS</italic> control. The transformed strains were tested for reversion of the <italic>argE3</italic> and <italic>galK2</italic> markers of the host strain as well as resistance to rifampicin. The results in <xref ref-type="table" rid="tbl1">Table 1</xref> and <xref ref-type="fig" rid="fig1">Figure 1</xref> show that the GM4799 strain with the <italic>mutS&#x00394;800</italic> or <italic>mutS</italic><sup>+</sup> plasmids did not display a mutator phenotype, but that GM4799 with <italic>mutS</italic>&#x00394;<italic>680</italic> plasmid did. The result with rifampicin resistance for the <italic>mutS&#x00394;800</italic> and <italic>mutS</italic><sup>+</sup> strains confirmed that obtained previously by Lamers <italic>et al</italic>. (<xref ref-type="bibr" rid="b22">22</xref>) and Biswas <italic>et al</italic>. (<xref ref-type="bibr" rid="b31">31</xref>). The reversion to Arg<sup>+</sup> and Gal<sup>+</sup> papillae formation was marginally higher in the GM4799 with the <italic>mutS</italic>&#x00394;800 plasmid culture compared to <italic>mutS</italic><sup>+</sup>, but both these values were much lower than in the <italic>mutS</italic>&#x00394;680 plasmid control strain. We conclude that the <italic>mutS</italic>&#x00394;<italic>800</italic> allele does not confer a mutator phenotype to the cell.</p></sec><sec><title>Interspecies crosses</title><p>Strain GM4799 with each of the <italic>mutS</italic> plasmids was used as a recipient in conjugal crosses with <italic>E.coli</italic> (homologous) or <italic>S.enterica</italic> Serovar <italic>Typhimurium</italic> (homeologous) donors. With the <italic>E.coli</italic> donor, AB259, recombinants were formed after 60 min of mating, at the same frequency with each GM4799 strain indicating no effect of the <italic>mutS</italic> alleles on homologous recombination (<xref ref-type="table" rid="tbl2">Table 2</xref>). With the <italic>Salmonella</italic> donors SA536 or SA977, however, the GM4799 recipient with the <italic>mutS</italic>&#x00394;800 plasmid formed recombinants 283- and 100-fold higher than the wild-type recipient, respectively. These values, however, are about half that for the GM4799 strain with the <italic>mutS</italic>&#x00394;<italic>680</italic> plasmid indicating that the <italic>mutS</italic>&#x00394;<italic>800</italic> allele does not completely relieve the inhibition produced by a fully proficient MMR system. The level of homeologous recombination was the same with either strain GM4799 or GM4799 containing the <italic>mutS</italic>&#x00394;<italic>680</italic> plasmid (data not shown).</p><p>To ensure that the results of the crosses described above were due to recombination, we repeated the crosses with a recombination-deficient (<italic>recA56</italic>) derivative of GM4799, GM5550. With the <italic>E.coli</italic> donor, AB259, no recombinants were detected in any of the crosses with the GM5550 recipients (data not shown). With the <italic>Salmonella</italic> donors, there was more than a 99% decrease in recombinant formation in the GM5550 strains with the <italic>mutS</italic>&#x00394;<italic>800</italic> and <italic>mutS</italic>&#x00394;<italic>680</italic> plasmids. We conclude that the <italic>mutS</italic>&#x00394;<italic>800</italic> mutation significantly reduces antirecombination in interspecies crosses in a <italic>recA</italic>-dependent manner.</p></sec><sec><title>Sensitivity to cytotoxic agents</title><p><italic>E.coli dam</italic> mutants are more sensitive to cisplatin and MNNG than wild type (<xref ref-type="bibr" rid="b11">11</xref>,<xref ref-type="bibr" rid="b12">12</xref>). <xref ref-type="fig" rid="fig2">Figure 2A</xref> shows that a <italic>dam mutS</italic> strain, GM5556, carrying the <italic>mutS</italic><sup>+</sup> plasmid is more sensitive to cisplatin than the same strain bearing the <italic>mutS&#x00394;680</italic> (null mutation) plasmid or the <italic>mutS&#x00394;800</italic> plasmid, indicating that the <italic>mutS</italic>&#x00394;800 gene product is unable to promote MMR sensitization. <xref ref-type="fig" rid="fig2">Figure 2A</xref> also shows that the survival of GM3819, a <italic>dam mutS</italic><sup>+</sup> strain, with the <italic>mutS&#x00394;800</italic> plasmid is the same as with a <italic>mutS</italic><sup>+</sup> plasmid. This result indicates that the <italic>mutS</italic>&#x00394;800 allele in multicopy does not have a dominant-negative phenotype in wild-type (<italic>mutS</italic><sup>+</sup>) cells.</p><p><xref ref-type="fig" rid="fig2">Figure 2B</xref> shows that when exposed to MNNG, the GM5556 strain with the <italic>mutS</italic><sup>+</sup> plasmid is sensitive but that with the <italic>mutS</italic>&#x00394;<italic>680</italic> plasmid is resistant. In contrast to the results with cisplatin, GM5556 with the <italic>mutS&#x00394;800</italic> plasmid has the same survival as the strain with the <italic>mutS</italic><sup>+</sup> plasmid.</p><p>The simplest interpretation of the data in <xref ref-type="fig" rid="fig2">Figure 2</xref> is that while the MutS&#x00394;800 protein is unable to recognize diguanyl platinated cross-links, it can recognize O<sup>6</sup>-meG mismatches with enough efficiency to produce the same phenotype in cells as MutS.</p></sec><sec><title>MutS and MutS&#x00394;800 binding to platinated oligonucleotides</title><p>To investigate if MutS and MutS&#x00394;800 have altered binding to cisplatin cross-links, we tested the ability of both proteins to bind to homoduplex, heteroduplex and platinated DNA substrates in an electrophoretic mobility shift assay. The data in <xref ref-type="fig" rid="fig3">Figure 3</xref> show that MutS&#x00394;800 has approximately the same affinity for P<sup>32</sup>-labeled heteroduplex DNA with a single base IDL as MutS. There was no significant binding of these proteins to a fully base-paired homoduplex substrate under the same experimental conditions (data not shown).</p><p>The substrates for MutS binding to platinated DNA included unplatinated homoduplex DNA, unplatinated heteroduplex DNA with a G&#x02013;T mismatch, and derivatives of each of these with a single intrastrand diguanyl cross-link (<xref ref-type="fig" rid="fig4">Figure 4</xref>). The unplatinated homoduplex acts as a negative control for the diguanyl cross-link paired with CC, and is considered to be a biologically relevant adduct produced from the reaction of cisplatin and DNA. The GG&#x02013;CT substrate acts as a positive control ensuring that MutS can bind to mismatched DNA in this sequence context. The mobility shifts shown in <xref ref-type="fig" rid="fig4">Figure 4</xref> were monitored by fluorescence after staining with VistraGreen. As expected, there was no detectable band shifting with MutS and MutS&#x00394;800 to unplatinated homoduplex DNA at the concentrations used for specific binding (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, lanes 2&#x02013;5). In contrast to the results in <xref ref-type="fig" rid="fig3">Figure 3</xref>, where MutS and MutS&#x00394;800 bind the IDL with near equivalent affinity, we did detect a difference in binding between MutS and MutS&#x00394;800 to the unplatinated heteroduplex containing a G&#x02013;T mismatch (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, lanes 2&#x02013;5). The addition of 4 &#x003bc;M of MutS produced a discernible retardation of the oligonucleotide (lane 3) while, at the same concentration, MutS&#x00394;800 did not (lane 5). At this concentration, MutS forms two distinct bands (lane 3), only one of which is present with MutS&#x00394;800 (lane 5) and may indicate that MutS first binds as a dimer and subsequently is converted to a tetramer. With 8 &#x003bc;M, the extent of heteroduplex binding by MutS&#x00394;800 was about 80% that of MutS (lanes 2 and 4).</p><p>There was a significant difference in binding of MutS and MutS&#x00394;800 to DNA with a GG cross-link opposite two C residues (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, lanes 6&#x02013;10). In fact, no binding of MutS&#x00394;800 to this DNA was observed (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, lanes 9 and 10) although MutS, at the same concentration, did produce a considerable band shift (<xref ref-type="fig" rid="fig4">Figure 4A</xref>, lanes 7 and 8). On the other hand, the DNA with a GG cross-link opposite CT residues, a product of translesion polymerase synthesis, was bound by MutS&#x00394;800 to about the same extent as MutS at 4 nM but less so at 8 nM due to partial shifting (<xref ref-type="fig" rid="fig4">Figure 4B</xref>, lanes 6&#x02013;10). With this substrate, the MutS and MutS&#x00394;800 upper bands are at about the same location. This could be due to MutS&#x00394;800 recognizing this substrate as a G&#x02013;T mismatch and the presence of the platinated guanines or that MutS&#x00394;800 arrays on this substrate to a greater extent than MutS.</p><p>The results in <xref ref-type="fig" rid="fig4">Figure 4C</xref> show that both MutS and MutS&#x00394;800 were able to bind to a duplex DNA with a single O<sup>6</sup>-meG&#x02013;C (lanes 1&#x02013;4) or O<sup>6</sup>-meG&#x02013;T (lanes 5&#x02013;8). There was no binding to homoduplex DNA at the concentrations used (data not shown). The difference in the binding affinities of MutS&#x00394;800 for the types of heteroduplexes used in <xref ref-type="fig" rid="fig3">Figures 3</xref> and <xref ref-type="fig" rid="fig4">4</xref> are relevant because the affinity of these proteins for the same substrate can differ due to sequence context or the type of mismatch or the affinity for base mismatches versus a one base IDL.</p><p>MutS&#x00394;800, therefore, has impaired specific binding of platinated intrastrand GG&#x02013;CC cross-links, but not intrastrand GG&#x02013;CT cross-links or a single base IDL or O<sup>6</sup>-meG&#x02013;C or O<sup>6</sup>-meG&#x02013;T mismatches. Since MutS can form tetramers while MutS&#x00394;800 cannot, this suggests that the ability to form tetramers could be necessary for efficient MutS processing of the biologically relevant platinated intrastrand cross-link.</p></sec><sec><title>RecA-mediated strand exchange <italic>in vitro</italic></title><p>In this assay, the ability of MutS to inhibit RecA-mediated strand transfer between M13&#x02013;M13 (homologous) and M13-fd (homeologous) phage DNA molecules is measured (<xref ref-type="bibr" rid="b8">8</xref>). <xref ref-type="fig" rid="fig5">Figure 5</xref> shows the results of a typical assay. For the M13&#x02013;M13 homologous substrates (lanes a&#x02013;e), nicked circle (NC) product and intermediate (I) bands are visible after 5 min (lane b) and these increase and decrease, respectively, during the reaction (lanes c&#x02013;e). The homeologous M13-fd reaction (lanes f&#x02013;j), is clearly slower, with no nicked circle product visible at 5 min (lane g) and a lower yield (72%) at 90 min (lane j). The graph in <xref ref-type="fig" rid="fig6">Figure 6</xref> shows that the addition of 100 nM MutS or MutS&#x00394;800 has no effect on the rate or yield of the reaction using the homologous M13&#x02013;M13 substrates. Addition of 25 or 100 nM MutS, however, reduces exchange between homeologous M13-fd substrates by 48% and 98%, respectively (<xref ref-type="fig" rid="fig6">Figure 6A</xref>). When MutS&#x00394;800 is added, the corresponding percentages were 22% and 58%, respectively (<xref ref-type="fig" rid="fig6">Figure 6B</xref>).</p><p>Worth <italic>et al</italic>. (<xref ref-type="bibr" rid="b8">8</xref>) showed that MutL stimulates MutS binding to M13-fd homeologous duplexes when the latter is at a sub-optimal concentration. In the experiment shown in <xref ref-type="fig" rid="fig6">Figure 6</xref>, 25 nM MutS or MutS&#x00394;800 only partially inhibits RecA-catalyzed strand transfer. Inclusion of MutL, at 15 or 40 nM to these reactions, however, completely abolishes RecA transfer activity (<xref ref-type="fig" rid="fig6">Figure 6</xref>) indicating that MutL dimers can interact with MutS or MutS&#x00394;800. MutL by itself had no effect on the rate or product yield in the reaction. We showed previously that there was no binding of MutL alone to platinated cross-linked DNA (<xref ref-type="bibr" rid="b17">17</xref>).</p></sec></sec><sec><title>DISCUSSION</title><p>The results described in this report show that MutS and MutS&#x00394;800 proteins, produced from multicopy plasmids, impart different properties to cells. Although cells with the MutS&#x00394;800 or MutS protein are not mutators (<xref ref-type="table" rid="tbl1">Table 1</xref> and <xref ref-type="fig" rid="fig1">Figure 1</xref>), the MutS&#x00394;800-containing cells are deficient in antirecombination (<xref ref-type="table" rid="tbl2">Table 2</xref>) and not sensitized to cisplatin cytotoxicity (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). This is the first demonstration of a separation of function phenotype for an <italic>E.coli mutS</italic> mutation. We propose that the C-terminal domain of MutS is required for efficient antirecombination and cisplatin sensitization, but not mutation avoidance or MNNG sensitization. Given that MutS&#x00394;800 can only form monomers and dimers, we postulate that the inability to form tetrameric MutS could be responsible for this phenotype. The data reported here also suggests that although MutS and MutS&#x00394;800 may bind base mismatches as dimers, conversion to the terameric form may be required for subsequent reactions in mismatch repair.</p><p>The results we have obtained in this report are best explained by the findings of Bjornson <italic>et al</italic>. (<xref ref-type="bibr" rid="b23">23</xref>) who have argued that the MutS tetramer is likely the active form of MutS in mutation avoidance. To support this conclusion, they found that MutS&#x00394;800 protein bound to mismatched DNA less efficiently than MutS. Our results also indicate that MutS&#x00394;800 does have reduced affinity for GG&#x02013;CT base mismatches (<xref ref-type="fig" rid="fig4">Figure 4B</xref>) but not with the one base IDL (<xref ref-type="fig" rid="fig3">Figure 3</xref>) or O<sup>6</sup>-meG mismatches (<xref ref-type="fig" rid="fig4">Figure 4C</xref>). Given that MutS&#x00394;800 has reduced affinity for some base mismatches, we propose that the lack of a mutator phenotype in cells over-expressing MutS&#x00394;800 (<xref ref-type="table" rid="tbl1">Table 1</xref> and <xref ref-type="fig" rid="fig1">Figure 1</xref>) can be explained by the MutS dimer being able to cope with the few mismatches generated behind the replication fork. The atomic structure of MutS&#x00394;800 indicates that mismatch binding does occur. In interspecies crosses, however, the much larger number of mismatches overwhelms the MutS&#x00394;800 protein's reduced mismatch binding and processing ability, thereby leading to reduced antirecombination as shown in <xref ref-type="table" rid="tbl2">Table 2</xref>. An essential part of our proposal, therefore, is that the cell's response with dimeric MutS depends on the number of mismatches involved; if there are few, overproduced dimeric MutS can substitute for tetrameric MutS at its normal cellular concentration. The data in <xref ref-type="fig" rid="fig5">Figures 5</xref> and <xref ref-type="fig" rid="fig6">6</xref>, showing a greater amount of M13-fd heteroduplex formation by MutS&#x00394;800 compared to MutS, is consistent with this model. The combination of MutL and MutS&#x00394;800 is as effective as MutS and MutL where the level of mismatching is 3%. We predict that at higher levels of mismatching, such as the 17% in <italic>E.coli</italic>&#x02013;<italic>Salmonella</italic> crosses, MutS&#x00394;800 would be much less effective than MutS, even in the presence of MutL.</p><p>Bjornson <italic>et al</italic>. (<xref ref-type="bibr" rid="b23">23</xref>) also showed that MutH-induced incision of heteroduplex DNA, in the presence of MutL, was reduced by MutS&#x00394;800. This observation can also help to explain the response of <italic>dam</italic> mutants with the over-expressed MutS&#x00394;800 protein to cisplatin and MNNG. For cells exposed to MNNG, there is sufficient binding of MutS&#x00394;800 to O<sup>6</sup>-meG mismatches to provoke a sensitization response even though there is reduced MutH-induced incision (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). For <italic>dam</italic> cells expressing MutS&#x00394;800 and exposed to cisplatin, however, the reduced binding of MutS&#x00394;800 to intrastrand diguanyl-cisplatin cross-links and the reduced MutH-induced incision activity allow the cell to repair, by recombination, the few DSBs that might be formed (<xref ref-type="fig" rid="fig2">Figure 2B</xref>).</p><p>The model proposed above regarding the number of mismatched base pairs and the ability of over-expressed MutS&#x00394;800 to deal with them makes the strong prediction that when MutS&#x00394;800 is expressed from a single-copy gene, the <italic>dam</italic> cells containing it would have different responses for spontaneous mutagenesis and resistance to cisplatin and MNNG compared to expression from a multicopy plasmid. Experiments to test this prediction are in progress.</p><p>Surprisingly, MutS&#x00394;800 when expressed in a wild-type background does not display a dominant negative phenotype with regard to cisplatin sensitivity (<xref ref-type="fig" rid="fig2">Figure 2</xref>). This result appears to rule out the possibility that MutS, which is at a low cellular concentration, could be titrated out by the plasmid expressed MutS&#x00394;800, leading to a dominant negative phenotype. We have not yet quantitated the protein levels of the plasmid expressed MutS&#x00394;800 versus the chromosomally expressed copy of MutS. If the MutS&#x00394;800 protein is less stable than MutS, then the ratio of the two proteins may be such that active mixed multimers are formed allowing for near-full functionality of the protein (<xref ref-type="fig" rid="fig2">Figure 2</xref>), which is absent in a population containing only the MutS&#x00394;800.</p><p>The results in <xref ref-type="fig" rid="fig4">Figure 4</xref> indicate that the C-terminal end of MutS is required for binding to platinated GG&#x02013;CC cross-links, which could also indicate a requirement for MutS tertamerization, in that the dimeric MutS&#x00394;800 cannot recognize the lesion, whereas the MutS does. At present, it is not known how this cross-link opposite CC differs in structure from that opposite CT to allow efficient recognition by MutS, but it is possible that binding to a platinated lesion requires critical contacts with residues residing in the C-terminus of MutS, offering an alternative to the tetramerization requirement. Furthermore, deletion of the C-terminus may disrupt the binding of MutS to low-affinity lesions, such as the intrastrand GG cross-links (10- to 40-fold lower than a G&#x02013;T mismatch (<xref ref-type="bibr" rid="b20">20</xref>,<xref ref-type="bibr" rid="b23">23</xref>), but not to a high affinity one base IDL (<xref ref-type="fig" rid="fig3">Figure 3</xref>). Either explanation is supported by the survival results for cells with the <italic>mutS&#x00394;800</italic> plasmid exposed to cisplatin (<xref ref-type="fig" rid="fig2">Figure 2</xref>). In addition to these alternatives to tetramerization, we cannot rule out a critical loss of interaction(s) between MutS&#x00394;800 and other proteins, such as the beta-clamp (<xref ref-type="bibr" rid="b32">32</xref>) which can ultimately affect the efficiency of recognition or repair processes.</p><p>That MutS can bind to platinated GG&#x02013;CC cross-links suggests that MMR-induced DSBs can occur in unreplicated DNA of <italic>dam</italic> mutants at these sequences, as well as cross-links opposite CT bases, which can be formed by translesion polymerases (<xref ref-type="bibr" rid="b33">33</xref>,<xref ref-type="bibr" rid="b34">34</xref>). Platinated GG&#x02013;CC cross-links can also be formed during recombinational repair of DSBs and these are bound by MutS which can block further branch migration (<xref ref-type="bibr" rid="b17">17</xref>), thereby preventing DSB repair. The ability of MutS to bind these cross-links can explain the observed cisplatin sensitivity of the <italic>dam mutS</italic><sup>+</sup> strain in <xref ref-type="fig" rid="fig2">Figure 2A</xref>. In contrast, the decreased binding of MutS&#x00394;800 to such lesions reduces the number of mismatch repair-induced DSBs and thereby promotes survival of the <italic>dam mutS&#x00394;800</italic> strain to cisplatin (<xref ref-type="fig" rid="fig2">Figure 2A</xref>).</p><p>Finally, we note that mammalian cell lines also show sensitivity to cisplatin and MNNG and MMR-deficient lines derived from them are resistant to both compounds (<xref ref-type="bibr" rid="b35">35</xref>,<xref ref-type="bibr" rid="b36">36</xref>), although whether cisplatin resistance is due specifically to MMR-deficiency has recently been challenged (<xref ref-type="bibr" rid="b37">37</xref>,<xref ref-type="bibr" rid="b38">38</xref>). Cisplatin-resistant cells isolated from patients treated with this drug have also been shown to be deficient in MMR (<xref ref-type="bibr" rid="b39">39</xref>). Like the bacterial MutS protein, the human MutS-alpha counterpart also binds to cisplatin intrastrand cross-links and O<sup>6</sup>-meG mismatches (<xref ref-type="bibr" rid="b40">40</xref>). The various models proposed to explain mismatch repair-dependent drug-resistance in mammalian cells have been reviewed in (<xref ref-type="bibr" rid="b41">41</xref>). The data reported here with <italic>E.coli</italic> MutS&#x00394;800 have no counterpart in eukaryotic systems, thereby preventing selection of one model over another.</p></sec></body><back><ack><p>We thank Meindert Lamers and Titia Sixma for the <italic>mutS</italic>&#x00394;C800 plasmid; Kenneth Sanderson for the <italic>Salmonella</italic> donor strains; Jennifer Robbins for construction and purification of the cross-linked platinated oligonucleotide; Dianne Schwarz for assistance with the radiolabeled band shifts; F. Lopez de Saro and M. O'Donnell for the gift of MutL protein and Mary Munson for invaluable help and guidance during protein purification. This work was supported by grant GM63790 from the National Institutes of Health. Funding to pay the Open Access publication charges for this article was provided by the National Institutes of Health.</p></ack><ref-list><title>REFERENCES</title><ref id="b1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Modrich</surname><given-names>P.</given-names></name><name><surname>Lahue</surname><given-names>R.</given-names></name></person-group><article-title>Mismatch repair in replication fidelity, genetic recombination, and cancer biology</article-title><source>Annu. Rev. Biochem.</source><year>1996</year><volume>65</volume><fpage>101</fpage><lpage>133</lpage><pub-id pub-id-type="pmid">8811176</pub-id></citation></ref><ref id="b2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schofield</surname><given-names>M.J.</given-names></name><name><surname>Hsieh</surname><given-names>P.</given-names></name></person-group><article-title>DNA mismatch repair: molecular mechanisms and biological function</article-title><source>Annu. Rev. Microbiol.</source><year>2003</year><volume>57</volume><fpage>579</fpage><lpage>608</lpage><pub-id pub-id-type="pmid">14527292</pub-id></citation></ref><ref id="b3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marti</surname><given-names>T.M.</given-names></name><name><surname>Kunz</surname><given-names>C.</given-names></name><name><surname>Fleck</surname><given-names>O.</given-names></name></person-group><article-title>DNA mismatch repair and mutation avoidance pathways</article-title><source>J. Cell Physiol.</source><year>2002</year><volume>191</volume><fpage>28</fpage><lpage>41</lpage><pub-id pub-id-type="pmid">11920679</pub-id></citation></ref><ref id="b4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rayssiguier</surname><given-names>C.</given-names></name><name><surname>Thaler</surname><given-names>D.S.</given-names></name><name><surname>Radman</surname><given-names>M.</given-names></name></person-group><article-title>The barrier to recombination between <italic>Escherichia coli</italic> and <italic>Salmonella typhimurium</italic> is disrupted in mismatch-repair mutants</article-title><source>Nature</source><year>1989</year><volume>342</volume><fpage>396</fpage><lpage>401</lpage><pub-id pub-id-type="pmid">2555716</pub-id></citation></ref><ref id="b5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Westmoreland</surname><given-names>J.</given-names></name><name><surname>Porter</surname><given-names>G.</given-names></name><name><surname>Radman</surname><given-names>M.</given-names></name><name><surname>Resnick</surname><given-names>M.A.</given-names></name></person-group><article-title>Highly mismatched molecules resembling recombination intermediates efficiently transform mismatch repair proficient <italic>Escherichia coli</italic></article-title><source>Genetics</source><year>1997</year><volume>145</volume><fpage>29</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">9017387</pub-id></citation></ref><ref id="b6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harfe</surname><given-names>B.D.</given-names></name><name><surname>Jinks-Robertson</surname><given-names>S.</given-names></name></person-group><article-title>DNA mismatch repair and genetic instability</article-title><source>Annu. Rev. Genet.</source><year>2000</year><volume>34</volume><fpage>359</fpage><lpage>399</lpage><pub-id pub-id-type="pmid">11092832</pub-id></citation></ref><ref id="b7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fabisiewicz</surname><given-names>A.</given-names></name><name><surname>Worth</surname><given-names>L.</given-names><suffix>Jr</suffix></name></person-group><article-title><italic>Escherichia coli</italic> MutS,L modulate RuvAB-dependent branch migration between diverged DNA</article-title><source>J. Biol. Chem.</source><year>2001</year><volume>276</volume><fpage>9413</fpage><lpage>9420</lpage><pub-id pub-id-type="pmid">11106642</pub-id></citation></ref><ref id="b8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Worth</surname><given-names>L.</given-names></name><name><surname>Clark</surname><given-names>S.R.M.</given-names></name><name><surname>Modrich</surname><given-names>P.</given-names></name></person-group><article-title>Mismatch repair proteins MutS and MutL inhibit RecA-catalyzed strand transfer between diverged DNAs</article-title><source>Proc. Natl Acad. Sci. USA</source><year>1994</year><volume>91</volume><fpage>3238</fpage><lpage>3241</lpage><pub-id pub-id-type="pmid">8159731</pub-id></citation></ref><ref id="b9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Junop</surname><given-names>M.S.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Funchain</surname><given-names>P.</given-names></name><name><surname>Clendenin</surname><given-names>W.</given-names></name><name><surname>Miller</surname><given-names>J.H.</given-names></name></person-group><article-title><italic>In vitro</italic> and <italic>in vivo</italic> studies of MutS, MutL and MutH mutants: correlation of mismatch repair and DNA recombination</article-title><source>DNA Repair (Amst.)</source><year>2003</year><volume>2</volume><fpage>387</fpage><lpage>405</lpage><pub-id pub-id-type="pmid">12606120</pub-id></citation></ref><ref id="b10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T.H.</given-names></name><name><surname>Marinus</surname><given-names>M.G.</given-names></name></person-group><article-title>Dominant negative mutator mutations in the <italic>mutS</italic> gene of <italic>Escherichia coli</italic></article-title><source>J. Bacteriol.</source><year>1994</year><volume>176</volume><fpage>5393</fpage><lpage>5400</lpage><pub-id pub-id-type="pmid">8071216</pub-id></citation></ref><ref id="b11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Karran</surname><given-names>P.</given-names></name><name><surname>Marinus</surname><given-names>M.G.</given-names></name></person-group><article-title>Mismatch correction at O<sup>6</sup>-methylguanine residues in <italic>E.coli</italic> DNA</article-title><source>Nature</source><year>1982</year><volume>296</volume><fpage>868</fpage><lpage>869</lpage><pub-id pub-id-type="pmid">7040986</pub-id></citation></ref><ref id="b12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fram</surname><given-names>R.J.</given-names></name><name><surname>Cusick</surname><given-names>P.S.</given-names></name><name><surname>Wilson</surname><given-names>J.M.</given-names></name><name><surname>Marinus</surname><given-names>M.G.</given-names></name></person-group><article-title>Mismatch repair of cis-diamminedichloroplatinum(II)-induced DNA damage</article-title><source>Mol. Pharmacol.</source><year>1985</year><volume>28</volume><fpage>51</fpage><lpage>55</lpage><pub-id pub-id-type="pmid">3894930</pub-id></citation></ref><ref id="b13"><label>13</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Marinus</surname><given-names>M.G.</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Higgins</surname><given-names>N.P.</given-names></name></person-group><article-title>Dr Jekyll and Mr Hyde: how the MutSLH repair system kills the cell</article-title><source>The Bacterial Chromosome</source><year>2005</year><publisher-loc>Washington, DC</publisher-loc><publisher-name>ASM Press</publisher-name><fpage>413</fpage><lpage>430</lpage></citation></ref><ref id="b14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Au</surname><given-names>K.G.</given-names></name><name><surname>Welsh</surname><given-names>K.</given-names></name><name><surname>Modrich</surname><given-names>P.</given-names></name></person-group><article-title>Initiation of methyl-directed mismatch repair</article-title><source>J. Biol. Chem.</source><year>1992</year><volume>267</volume><fpage>12142</fpage><lpage>12148</lpage><pub-id pub-id-type="pmid">1601880</pub-id></citation></ref><ref id="b15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marinus</surname><given-names>M.G.</given-names></name></person-group><article-title>Recombination is essential for viability of an <italic>Escherichia coli dam</italic> (DNA adenine methyltransferase) mutant</article-title><source>J. Bacteriol.</source><year>2000</year><volume>182</volume><fpage>463</fpage><lpage>468</lpage><pub-id pub-id-type="pmid">10629194</pub-id></citation></ref><ref id="b16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nowosielska</surname><given-names>A.</given-names></name><name><surname>Marinus</surname><given-names>M.G.</given-names></name></person-group><article-title>Cisplatin induces DNA double-strand break formation in <italic>Escherichia coli dam</italic> mutants</article-title><source>DNA Repair (Amst.)</source><year>2005</year><comment>in press</comment></citation></ref><ref id="b17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Calmann</surname><given-names>M.A.</given-names></name><name><surname>Marinus</surname><given-names>M.G.</given-names></name></person-group><article-title>MutS inhibits RecA-mediated strand exchange with platinated DNA substrates</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2004</year><volume>101</volume><fpage>14174</fpage><lpage>14179</lpage><pub-id pub-id-type="pmid">15375217</pub-id></citation></ref><ref id="b18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>S.S.</given-names></name><name><surname>Modrich</surname><given-names>P.</given-names></name></person-group><article-title><italic>Escherichia coli mutS</italic>-encoded protein binds to mismatched DNA base pairs</article-title><source>Proc. Natl Acad. Sci. USA</source><year>1986</year><volume>83</volume><fpage>5057</fpage><lpage>5061</lpage><pub-id pub-id-type="pmid">3014530</pub-id></citation></ref><ref id="b19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parker</surname><given-names>B.O.</given-names></name><name><surname>Marinus</surname><given-names>M.G.</given-names></name></person-group><article-title>Repair of DNA heteroduplexes containing small heterologous sequences in <italic>Escherichia coli</italic></article-title><source>Proc. Natl Acad. Sci. USA</source><year>1992</year><volume>89</volume><fpage>1730</fpage><lpage>1734</lpage><pub-id pub-id-type="pmid">1542666</pub-id></citation></ref><ref id="b20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fourrier</surname><given-names>L.</given-names></name><name><surname>Brooks</surname><given-names>P.</given-names></name><name><surname>Malinge</surname><given-names>J.M.</given-names></name></person-group><article-title>Binding discrimination of MutS to a set of lesions and compound lesions (base damage and mismatch) reveals its potential role as a cisplatin-damaged DNA sensing protein</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>21267</fpage><lpage>21275</lpage><pub-id pub-id-type="pmid">12654906</pub-id></citation></ref><ref id="b21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rasmussen</surname><given-names>L.J.</given-names></name><name><surname>Samson</surname><given-names>L.</given-names></name></person-group><article-title>The <italic>Escherichia coli</italic> MutS DNA mismatch binding protein specifically binds O(6)-methylguanine DNA lesions</article-title><source>Carcinogenesis</source><year>1996</year><volume>17</volume><fpage>2085</fpage><lpage>2088</lpage><pub-id pub-id-type="pmid">8824540</pub-id></citation></ref><ref id="b22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lamers</surname><given-names>M.H.</given-names></name><name><surname>Perrakis</surname><given-names>A.</given-names></name><name><surname>Enzlin</surname><given-names>J.H.</given-names></name><name><surname>Winterwerp</surname><given-names>H.H.</given-names></name><name><surname>de Wind</surname><given-names>N.</given-names></name><name><surname>Sixma</surname><given-names>T.K.</given-names></name></person-group><article-title>The crystal structure of DNA mismatch repair protein MutS binding to a G &#x000d7; T mismatch</article-title><source>Nature</source><year>2000</year><volume>407</volume><fpage>711</fpage><lpage>717</lpage><pub-id pub-id-type="pmid">11048711</pub-id></citation></ref><ref id="b23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bjornson</surname><given-names>K.P.</given-names></name><name><surname>Blackwell</surname><given-names>L.J.</given-names></name><name><surname>Sage</surname><given-names>H.</given-names></name><name><surname>Baitinger</surname><given-names>C.</given-names></name><name><surname>Allen</surname><given-names>D.</given-names></name><name><surname>Modrich</surname><given-names>P.</given-names></name></person-group><article-title>Assembly and molecular activities of the MutS tetramer</article-title><source>J. Biol. Chem.</source><year>2003</year><volume>278</volume><fpage>34667</fpage><lpage>34673</lpage><pub-id pub-id-type="pmid">12829697</pub-id></citation></ref><ref id="b24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Takamatsu</surname><given-names>S.</given-names></name><name><surname>Kato</surname><given-names>R.</given-names></name><name><surname>Kuramitsu</surname><given-names>S.</given-names></name></person-group><article-title>Mismatch DNA recognition protein from an extremely thermophilic bacterium, <italic>Thermus thermophilus</italic> HB8</article-title><source>Nucleic Acids Res.</source><year>1996</year><volume>24</volume><fpage>640</fpage><lpage>647</lpage><pub-id pub-id-type="pmid">8604304</pub-id></citation></ref><ref id="b25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>I.</given-names></name><name><surname>Ban</surname><given-names>C.</given-names></name><name><surname>Fleming</surname><given-names>K.G.</given-names></name><name><surname>Qin</surname><given-names>J.</given-names></name><name><surname>Lary</surname><given-names>J.W.</given-names></name><name><surname>Yphantis</surname><given-names>D.A.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Hsieh</surname><given-names>P.</given-names></name></person-group><article-title>Oligomerization of a MutS mismatch repair protein from <italic>Thermus aquaticus</italic></article-title><source>J. Biol. Chem.</source><year>1999</year><volume>274</volume><fpage>23673</fpage><lpage>23678</lpage><pub-id pub-id-type="pmid">10438551</pub-id></citation></ref><ref id="b26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Obmolova</surname><given-names>G.</given-names></name><name><surname>Ban</surname><given-names>C.</given-names></name><name><surname>Hsieh</surname><given-names>P.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name></person-group><article-title>Crystal structures of mismatch repair protein MutS and its complex with a substrate DNA</article-title><source>Nature</source><year>2000</year><volume>407</volume><fpage>703</fpage><lpage>710</lpage><pub-id pub-id-type="pmid">11048710</pub-id></citation></ref><ref id="b27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>T.H.</given-names></name><name><surname>Marinus</surname><given-names>M.G.</given-names></name></person-group><article-title>Deletion mutation analysis of the <italic>mutS</italic> gene in <italic>Escherichia coli</italic></article-title><source>J. Biol. Chem.</source><year>1999</year><volume>274</volume><fpage>5948</fpage><lpage>5952</lpage><pub-id pub-id-type="pmid">10026220</pub-id></citation></ref><ref id="b28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marinus</surname><given-names>M.G.</given-names></name><name><surname>Morris</surname><given-names>N.R.</given-names></name></person-group><article-title>Biological function for 6-methyladenine residues in the DNA of <italic>Escherichia coli</italic> K12</article-title><source>J. Mol. Biol.</source><year>1974</year><volume>85</volume><fpage>309</fpage><lpage>322</lpage><pub-id pub-id-type="pmid">4600143</pub-id></citation></ref><ref id="b29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nowosielska</surname><given-names>A.</given-names></name><name><surname>Calmann</surname><given-names>M.A.</given-names></name><name><surname>Zdraveski</surname><given-names>Z.</given-names></name><name><surname>Essigmann</surname><given-names>J.M.</given-names></name><name><surname>Marinus</surname><given-names>M.G.</given-names></name></person-group><article-title>Spontaneous and cisplatin-induced recombination in <italic>Escherichia coli</italic></article-title><source>DNA Repair (Amst.)</source><year>2004</year><volume>3</volume><fpage>719</fpage><lpage>728</lpage><pub-id pub-id-type="pmid">15177181</pub-id></citation></ref><ref id="b30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rosen</surname><given-names>H.</given-names></name></person-group><article-title>A modified ninhydrin colorimetric analysis for amino acids</article-title><source>Arch. Biochim. Biophys.</source><year>1957</year><volume>67</volume><fpage>10</fpage><lpage>15</lpage></citation></ref><ref id="b31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>I.</given-names></name><name><surname>Obmolova</surname><given-names>G.</given-names></name><name><surname>Takahashi</surname><given-names>M.</given-names></name><name><surname>Herr</surname><given-names>A.</given-names></name><name><surname>Newman</surname><given-names>M.A.</given-names></name><name><surname>Yang</surname><given-names>W.</given-names></name><name><surname>Hsieh</surname><given-names>P.</given-names></name></person-group><article-title>Disruption of the helix&#x02013;u-turn&#x02013;helix motif of MutS protein: loss of subunit dimerization, mismatch binding and ATP hydrolysis</article-title><source>J. Mol. Biol.</source><year>2001</year><volume>305</volume><fpage>805</fpage><lpage>816</lpage><pub-id pub-id-type="pmid">11162093</pub-id></citation></ref><ref id="b32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lopez de Saro</surname><given-names>F.J.</given-names></name><name><surname>O'Donnell</surname><given-names>M.</given-names></name></person-group><article-title>Interaction of the beta sliding clamp with MutS, ligase, and DNA polymerase I</article-title><source>Proc. Natl Acad. Sci. USA</source><year>2001</year><volume>98</volume><fpage>8376</fpage><lpage>8380</lpage><pub-id pub-id-type="pmid">11459978</pub-id></citation></ref><ref id="b33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaisman</surname><given-names>A.</given-names></name><name><surname>Chaney</surname><given-names>S.G.</given-names></name></person-group><article-title>The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase beta</article-title><source>J. Biol. Chem.</source><year>2000</year><volume>275</volume><fpage>13017</fpage><lpage>13025</lpage><pub-id pub-id-type="pmid">10777605</pub-id></citation></ref><ref id="b34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaisman</surname><given-names>A.</given-names></name><name><surname>Masutani</surname><given-names>C.</given-names></name><name><surname>Hanaoka</surname><given-names>F.</given-names></name><name><surname>Chaney</surname><given-names>S.G.</given-names></name></person-group><article-title>Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta</article-title><source>Biochemistry</source><year>2000</year><volume>39</volume><fpage>4575</fpage><lpage>4580</lpage><pub-id pub-id-type="pmid">10769112</pub-id></citation></ref><ref id="b35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Branch</surname><given-names>P.</given-names></name><name><surname>Masson</surname><given-names>M.</given-names></name><name><surname>Aquilina</surname><given-names>G.</given-names></name><name><surname>Bignami</surname><given-names>M.</given-names></name><name><surname>Karran</surname><given-names>P.</given-names></name></person-group><article-title>Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells</article-title><source>Oncogene</source><year>2000</year><volume>19</volume><fpage>3138</fpage><lpage>3145</lpage><pub-id pub-id-type="pmid">10918568</pub-id></citation></ref><ref id="b36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kartalou</surname><given-names>M.</given-names></name><name><surname>Essigmann</surname><given-names>J.M.</given-names></name></person-group><article-title>Mechanisms of resistance to cisplatin</article-title><source>Mutat. Res.</source><year>2001</year><volume>478</volume><fpage>23</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">11406167</pub-id></citation></ref><ref id="b37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Massey</surname><given-names>A.</given-names></name><name><surname>Offman</surname><given-names>J.</given-names></name><name><surname>Macpherson</surname><given-names>P.</given-names></name><name><surname>Karran</surname><given-names>P.</given-names></name></person-group><article-title>DNA mismatch repair and acquired cisplatin resistance in <italic>E. coli</italic> and human ovarian carcinoma cells</article-title><source>DNA Repair (Amst.)</source><year>2003</year><volume>2</volume><fpage>73</fpage><lpage>89</lpage><pub-id pub-id-type="pmid">12509269</pub-id></citation></ref><ref id="b38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Claij</surname><given-names>N.</given-names></name><name><surname>Te Riele</surname><given-names>H.</given-names></name></person-group><article-title>Msh2 deficiency does not contribute to cisplatin resistance in mouse embryonic stem cells</article-title><source>Oncogene</source><year>2004</year><volume>23</volume><fpage>260</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">14712231</pub-id></citation></ref><ref id="b39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fink</surname><given-names>D.</given-names></name><name><surname>Nebel</surname><given-names>S.</given-names></name><name><surname>Aebi</surname><given-names>S.</given-names></name><name><surname>Zheng</surname><given-names>H.</given-names></name><name><surname>Cenni</surname><given-names>B.</given-names></name><name><surname>Nehme</surname><given-names>A.</given-names></name><name><surname>Christen</surname><given-names>R.D.</given-names></name><name><surname>Howell</surname><given-names>S.B.</given-names></name></person-group><article-title>The role of DNA mismatch repair in platinum drug resistance</article-title><source>Cancer Res.</source><year>1996</year><volume>56</volume><fpage>4881</fpage><lpage>4886</lpage><pub-id pub-id-type="pmid">8895738</pub-id></citation></ref><ref id="b40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Duckett</surname><given-names>D.R.</given-names></name><name><surname>Drummond</surname><given-names>J.T.</given-names></name><name><surname>Murchie</surname><given-names>A.I.</given-names></name><name><surname>Reardon</surname><given-names>J.T.</given-names></name><name><surname>Sancar</surname><given-names>A.</given-names></name><name><surname>Lilley</surname><given-names>D.M.</given-names></name><name><surname>Modrich</surname><given-names>P.</given-names></name></person-group><article-title>Human MutSalpha recognizes damaged DNA base pairs containing O<sup>6</sup>-methylguanine, O4-methylthymine, or the cisplatin-d(GpG) adduct</article-title><source>Proc. Natl Acad. Sci. USA</source><year>1996</year><volume>93</volume><fpage>6443</fpage><lpage>6447</lpage><pub-id pub-id-type="pmid">8692834</pub-id></citation></ref><ref id="b41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stojic</surname><given-names>L.</given-names></name><name><surname>Brun</surname><given-names>R.</given-names></name><name><surname>Jiricny</surname><given-names>J.</given-names></name></person-group><article-title>Mismatch repair and DNA damage signalling</article-title><source>DNA Repair (Amst.)</source><year>2004</year><volume>3</volume><fpage>1091</fpage><lpage>1101</lpage><pub-id pub-id-type="pmid">15279797</pub-id></citation></ref></ref-list><sec sec-type="display-objects"><title>Figures and Tables</title><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Gal reversion assay. Dark Gal<sup>+</sup> revertants are shown on a background of white Gal<sup>&#x02212;</sup> colonies. From left to right: the GM4799 strain (<italic>mutS</italic> null mutation) with plasmids bearing <italic>mutS</italic><sup>+</sup>, <italic>mutS&#x00394;680</italic> and <italic>mutS&#x00394;800</italic>, respectively.</p></caption><graphic xlink:href="gki263f1"/></fig><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Survival of cells exposed to cisplatin and MNNG. Cell survival of strain GM5556 (&#x00394;<italic>dam-16</italic>::Kan <italic>mutS</italic>::Tn<italic>10</italic>) containing plasmids with <italic>mutS</italic><sup>+</sup> (closed circles), <italic>mutS</italic>&#x00394;<italic>680</italic> (inverted triangles), and <italic>mutS</italic>&#x00394;<italic>800</italic> (closed squares) after exposure to cisplatin (<bold>A</bold>) and MNNG (<bold>B</bold>). The open squares in (A) represent the survival of GM3819 (&#x00394;<italic>dam-16</italic>::Kan <italic>mutS</italic><sup>+</sup>) with the <italic>mutS</italic>&#x00394;<italic>800</italic> plasmid.</p></caption><graphic xlink:href="gki263f2"/></fig><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Binding isotherm of MutS and MutS&#x00394;800 to heteroduplex DNA. The upper panel shows the binding of MutS and MutS&#x00394;800 to a P<sup>32</sup>-labeled heteroduplex DNA with a single base IDL. The heteroduplex concentration was 0.6 pmol. The data are shown in the lower panel as a binding isotherm.</p></caption><graphic xlink:href="gki263f3"/></fig><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Binding of MutS and MutS&#x00394;800 to modified DNA. (<bold>A</bold>) The binding of MutS and MutS&#x00394;800 to unplatinated (lanes 1&#x02013;5) and platinated homoduplex (lanes 6&#x02013;10) DNA. No enzyme (lanes 1 and 6); MutS, 8 &#x003bc;M (lanes 2 and 7) and 4 &#x003bc;M (lanes 3 and 8); and MutS&#x00394;800, 8 &#x003bc;M (lanes 4 and 9) and 4 &#x003bc;M (lanes 5 and 10). The DNA was visualized by staining the gel with Vistra Green. (<bold>B</bold>) The binding of MutS and MutS&#x00394;800 to unplatinated (lanes 1&#x02013;5) and platinated heteroduplex (lanes 6&#x02013;10). Protein additions are the same as in (A). (<bold>C</bold>) The binding of MutS and MutS&#x00394;800 to O<sup>6</sup>-meG&#x02013;C (lanes 1&#x02013;4) and O<sup>6</sup>-meG&#x02013;T (lanes 5&#x02013;8) DNA. MutS, 8 &#x003bc;M (lanes 1 and 5) and 16 &#x003bc;M (lanes 2 and 6); and MutS&#x00394;800, 8 &#x003bc;M (lanes 3 and 7) and 16 &#x003bc;M (lanes 4 and 8).</p></caption><graphic xlink:href="gki263f4"/></fig><fig id="fig5" position="float"><label>Figure 5</label><caption><p>RecA-catalyzed strand transfer. The upper panel shows a schematic diagram of the reaction. Single-strand (SS) circular DNA reacts with linear (L) duplex to form intermediate (I) structures which are converted into nicked-circle (NC) products. The fluorograph shows the results from the homologous M13&#x02013;M13 (lanes a&#x02013;e) and the homeologous M13-fd (lanes f&#x02013;j) reactions. Samples were removed at time 0 (lanes a and f), 5 min (lanes b and g), 15 min (lanes c and h), 45 min (lanes d and i) and 90 min (lanes e and j).</p></caption><graphic xlink:href="gki263f5"/></fig><fig id="fig6" position="float"><label>Figure 6</label><caption><p>Kinetics of MutS inhibition of RecA-mediated strand exchange. The graphs show the effect of varying concentrations of MutS (<bold>A</bold>) and MutS&#x00394;800 (<bold>B</bold>) on RecA strand exchange using homologous (M13&#x02013;M13) and homeologous (M13-fd). Closed circles, M13&#x02013;M13; crosses, M13&#x02013;M13 plus 100 nM protein; closed squares, M13-fd; open squares, M13-fd plus 25 nM protein; open circles, M13-fd plus 100 nM protein; and inverted triangles, M13-fd plus 25 nM protein plus 40 nM MutL.</p></caption><graphic xlink:href="gki263f6"/></fig><table-wrap id="tbl1" position="float"><label>Table 1</label><caption><p>Spontaneous mutant frequencies</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Plasmid allele</th><th align="left" colspan="1" rowspan="1">Arg<sup>+</sup></th><th align="left" colspan="1" rowspan="1">Rif<sup>R</sup></th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">MutS<sup>+</sup></td><td align="right" colspan="1" rowspan="1">4</td><td align="right" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">mutS&#x00394;680</td><td align="right" colspan="1" rowspan="1">66</td><td align="right" colspan="1" rowspan="1">72</td></tr><tr><td align="left" colspan="1" rowspan="1">mutS&#x00394;800</td><td align="right" colspan="1" rowspan="1">8</td><td align="right" colspan="1" rowspan="1">1</td></tr></tbody></table><table-wrap-foot><fn><p>Cultures of strain GM4799 (<italic>mutS</italic> null mutation) with the indicated plasmid allele were plated on media selective for rifampicin-resistance or arginine prototrophy. The numbers represent mutant colonies per 10<sup>8</sup> cells plated.</p></fn></table-wrap-foot></table-wrap><table-wrap id="tbl2" position="float"><label>Table 2</label><caption><p>Yield of recombinants in homologous and homeologous crosses</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Donor</th><th align="left" colspan="1" rowspan="1">Plasmid in recipient</th><th align="left" colspan="1" rowspan="1">Recipient</th><th align="left" colspan="1" rowspan="1">Selected marker(s)</th><th align="left" colspan="1" rowspan="1">Frequency</th><th align="left" colspan="1" rowspan="1">Fold increase</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">AB259</td><td align="left" colspan="1" rowspan="1"><italic>mutS</italic><sup>+</sup></td><td align="left" colspan="1" rowspan="1">Rec<sup>+</sup></td><td align="left" colspan="1" rowspan="1">Thr<sup>+</sup> Leu<sup>+</sup></td><td align="char" char="&#x000d7;" colspan="1" rowspan="1">2.8 &#x000d7; 10<sup>5</sup></td><td align="left" colspan="1" rowspan="1">&#x02014;</td></tr><tr><td align="left" colspan="1" rowspan="1">AB259</td><td align="left" colspan="1" rowspan="1"><italic>mutS</italic>&#x00394;680</td><td align="left" colspan="1" rowspan="1">Rec<sup>+</sup></td><td align="left" colspan="1" rowspan="1">Thr<sup>+</sup> Leu<sup>+</sup></td><td align="char" char="&#x000d7;" colspan="1" rowspan="1">2.5 &#x000d7; 10<sup>5</sup></td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">AB259</td><td align="left" colspan="1" rowspan="1"><italic>mutS</italic>&#x00394;800</td><td align="left" colspan="1" rowspan="1">Rec<sup>+</sup></td><td align="left" colspan="1" rowspan="1">Thr<sup>+</sup> Leu<sup>+</sup></td><td align="char" char="&#x000d7;" colspan="1" rowspan="1">2.0 &#x000d7; 10<sup>5</sup></td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">SA536</td><td align="left" colspan="1" rowspan="1"><italic>mutS</italic><sup>+</sup></td><td align="left" colspan="1" rowspan="1">Rec<sup>+</sup></td><td align="left" colspan="1" rowspan="1">Arg<sup>+</sup></td><td align="right" colspan="1" rowspan="1">120</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">SA536</td><td align="left" colspan="1" rowspan="1"><italic>mutS</italic>&#x00394;680</td><td align="left" colspan="1" rowspan="1">Rec<sup>+</sup></td><td align="left" colspan="1" rowspan="1">Arg<sup>+</sup></td><td align="right" colspan="1" rowspan="1">59&#x02009;000</td><td align="left" colspan="1" rowspan="1">492</td></tr><tr><td align="left" colspan="1" rowspan="1">SA536</td><td align="left" colspan="1" rowspan="1"><italic>mutS</italic>&#x00394;800</td><td align="left" colspan="1" rowspan="1">Rec<sup>+</sup></td><td align="left" colspan="1" rowspan="1">Arg<sup>+</sup></td><td align="right" colspan="1" rowspan="1">34&#x02009;000</td><td align="left" colspan="1" rowspan="1">283</td></tr><tr><td align="left" colspan="1" rowspan="1">SA977</td><td align="left" colspan="1" rowspan="1"><italic>mutS</italic><sup>+</sup></td><td align="left" colspan="1" rowspan="1">Rec<sup>+</sup></td><td align="left" colspan="1" rowspan="1">Arg<sup>+</sup></td><td align="right" colspan="1" rowspan="1">35</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">SA977</td><td align="left" colspan="1" rowspan="1"><italic>mutS</italic>&#x00394;680</td><td align="left" colspan="1" rowspan="1">Rec<sup>+</sup></td><td align="left" colspan="1" rowspan="1">Arg<sup>+</sup></td><td align="right" colspan="1" rowspan="1">10&#x02009;665</td><td align="left" colspan="1" rowspan="1">296</td></tr><tr><td align="left" colspan="1" rowspan="1">SA977</td><td align="left" colspan="1" rowspan="1"><italic>mutS</italic>&#x00394;800</td><td align="left" colspan="1" rowspan="1">Rec<sup>+</sup></td><td align="left" colspan="1" rowspan="1">Arg<sup>+</sup></td><td align="right" colspan="1" rowspan="1">3410</td><td align="left" colspan="1" rowspan="1">100</td></tr><tr><td align="left" colspan="1" rowspan="1">SA536</td><td align="left" colspan="1" rowspan="1"><italic>mutS</italic><sup>+</sup></td><td align="left" colspan="1" rowspan="1">recA56</td><td align="left" colspan="1" rowspan="1">Arg<sup>+</sup></td><td align="right" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">SA536</td><td align="left" colspan="1" rowspan="1"><italic>mutS</italic>&#x00394;680</td><td align="left" colspan="1" rowspan="1">recA56</td><td align="left" colspan="1" rowspan="1">Arg<sup>+</sup></td><td align="right" colspan="1" rowspan="1">80</td><td align="left" colspan="1" rowspan="1">2.7</td></tr><tr><td align="left" colspan="1" rowspan="1">SA536</td><td align="left" colspan="1" rowspan="1"><italic>mutS</italic>&#x00394;800</td><td align="left" colspan="1" rowspan="1">recA56</td><td align="left" colspan="1" rowspan="1">Arg<sup>+</sup></td><td align="right" colspan="1" rowspan="1">60</td><td align="left" colspan="1" rowspan="1">2</td></tr><tr><td align="left" colspan="1" rowspan="1">SA977</td><td align="left" colspan="1" rowspan="1"><italic>mutS</italic><sup>+</sup></td><td align="left" colspan="1" rowspan="1">recA56</td><td align="left" colspan="1" rowspan="1">Arg<sup>+</sup></td><td align="right" colspan="1" rowspan="1">8</td><td align="left" colspan="1" rowspan="1">1</td></tr><tr><td align="left" colspan="1" rowspan="1">SA977</td><td align="left" colspan="1" rowspan="1"><italic>mutS</italic>&#x00394;680</td><td align="left" colspan="1" rowspan="1">recA56</td><td align="left" colspan="1" rowspan="1">Arg<sup>+</sup></td><td align="right" colspan="1" rowspan="1">120</td><td align="left" colspan="1" rowspan="1">15</td></tr><tr><td align="left" colspan="1" rowspan="1">SA977</td><td align="left" colspan="1" rowspan="1"><italic>mutS</italic>&#x00394;800</td><td align="left" colspan="1" rowspan="1">recA56</td><td align="left" colspan="1" rowspan="1">Arg<sup>+</sup></td><td align="right" colspan="1" rowspan="1">85</td><td align="left" colspan="1" rowspan="1">10</td></tr></tbody></table><table-wrap-foot><fn><p>Donor and recipient (GM4799 and GM5550) cultures (at 1&#x02013;2 &#x000d7; 10<sup>8</sup> cells per ml) were mated for 60 min (AB259) or 3 h (SA strains). The numbers in the table represent the Thr<sup>+</sup> Leu<sup>+</sup> [Str<sup>R</sup>] or Arg<sup>+</sup> [Str<sup>R</sup>] recombinants in 50 &#x003bc;l of undiluted mating mixture.</p></fn></table-wrap-foot></table-wrap></sec></back></article> 